Helen Sheridan
Corporate Officer/Principal chez Irish Medicines Board
Profil
Helen Sheridan is the founder of Trino Therapeutics Ltd., which was founded in 1999.
She held the title of Principal Chemist & IP Specialist from 1999 to 2012.
Currently, she is a Member of the Irish Medicines Board.
Dr. Sheridan received a doctorate degree from University College Dublin.
Postes actifs de Helen Sheridan
| Sociétés | Poste | Début |
|---|---|---|
| Irish Medicines Board | Corporate Officer/Principal | - |
Anciens postes connus de Helen Sheridan
| Sociétés | Poste | Fin |
|---|---|---|
Trino Therapeutics Ltd.
 Trino Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Trino Therapeutics Ltd. operates as a drug discovery and development company. It focuses on developing oral small molecules for the treatment and unmet management of inflammatory bowel disease and other inflammatory indications. The company was founded by Neil Howard Frankish and Helen Sheridan in 1999 and is headquartered in Dublin, Ireland. | Fondateur | - |
Formation de Helen Sheridan
| University College Dublin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Trino Therapeutics Ltd.
Trino Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Trino Therapeutics Ltd. operates as a drug discovery and development company. It focuses on developing oral small molecules for the treatment and unmet management of inflammatory bowel disease and other inflammatory indications. The company was founded by Neil Howard Frankish and Helen Sheridan in 1999 and is headquartered in Dublin, Ireland. | Health Technology |
| Irish Medicines Board |
